|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Dr. Roy Altman Joins BioChemics, Inc. Scientific Advisory Board to Advise on Clinical Development of Targeted Osteoarthritis Therapy
5/7/2008 11:15:22 AM
DANVERS, Mass.--(BUSINESS WIRE)--BioChemics, Inc., a company “pioneering transdermal drug delivery,” is pleased to announce that Dr. Roy D. Altman, Professor of Medicine, Division of Rheumatology and Immunology at the University of California, Los Angeles and Past President of the Osteoarthritis Research Society International has elected to serve as a member of the Company’s Scientific Advisory Board (SAB). Dr. Altman will be providing strategic input into the clinical development of the company’s targeted, topical, non steroidal anti-inflammatory (NSAID) product to treat osteoarthritis.
|
|
|
|
|
|
|
|
|
|
|